North America remains a dominant regional hub for cell line development due to its well-established healthcare infrastructure, strong biotechnology research capabilities, and rising demand for biologic therapeutics. The region benefits from increasing investments in biopharmaceutical manufacturing, growing adoption of personalized medicine, and expanding research activities focused on cancer...